Dasantafil is an investigational phosphodiesterase-5 (PDE5) inhibitor developed for the management of erectile dysfunction. By selectively inhibiting the PDE5 enzyme, this compound helps regulate cyclic… Read more
Dasantafil is an investigational phosphodiesterase-5 (PDE5) inhibitor developed for the management of erectile dysfunction. By selectively inhibiting the PDE5 enzyme, this compound helps regulate cyclic GMP levels, promoting smooth muscle relaxation and improving blood flow. The Dasantafil category provides essential analytical tools, including high-quality reference standards and stable isotope labelled compounds like Dasantafil-13C-d3. These materials are critical for pharmaceutical laboratories performing impurity profiling, method development, and rigorous quality control. Using these labelled standards allows researchers to accurately quantify the active pharmaceutical ingredient and track degradation products or process-related impurities during stability testing. Analytical chemists rely on these precise reference materials to ensure compliance with regulatory standards and to maintain the integrity of their drug analysis protocols throughout the lifecycle of the development process.